Log In
Print
BCIQ
Print
Print this Print this
 

KAR4141

  Manage Alerts
Collapse Summary General Information
Company Karus Therapeutics Ltd.
DescriptionPhosphoinositide 3-kinase (PI3K) p110 delta inhibitors
Molecular Target Phosphoinositide 3-kinase (PI3K)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Inflammation (unspecified)
Indication DetailsTreat inflammation
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today